Rochester, Minn. — Mayo Clinic is the prime site for an ARPA-H award to develop an implantable device that acts as a living pharmacy, triggering a “cell factory” in the body to treat inflammatory disease. ARPA-H, short for Advanced Research Projects Agency for Health, is an agency within the Department of Health and Human Services. It supports research for potentially transformative biomedical and health breakthroughs. The award for up to $42.8 million for Engage Assess…
You may also like
Health & Wellness
Mayo Clinic Q and A: My mom has Alzheimer’s. What does that mean for me?
Editor’s Note: September is World Alzheimer’s Month DEAR MAYO CLINIC: I am part of what I hear called the Sandwich
Health & Wellness
Mayo Clinic Minute: Palliative medicine for cancer patients
Patients undergoing cancer treatments often use palliative medicine to cope with nausea, fatigue and other bothersome symptoms. Palliative medicine is